Fluoxetine (Prozac) has emerged from a small trial as a  medicine warranting futher study as a potential treatment for multiple sclerosis. The drug has been used extensively to treat depression associated with the disease and this study indicates some anti-inflammatory mechanisms that may be of benefit to patients as well.